ClinicalTrials.gg
RecruitingNCT06918041Updated Jul 8, 2026

FiberLocker® System Augmentation of Rotator Cuff Repairs

An interventional study of FiberLocker® System (encompassing FiberLocker® Instrument & SpeedPatch® PET) in Rotator Cuff Tear, Rotator Cuff Tears and Rotator Cuff Tears of the Shoulder, sponsored by ZuriMED Technologies Inc.. Recruiting at 4 sites in United States. Open to participants aged 30 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-07-08.

Sponsored by ZuriMED Technologies Inc. · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2025; still recruiting 1 year 3 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
30 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 168 studies in Rotator Cuff Injuries with a site in United States — 40 open to participants now, 50 under way, none of them phase 3. Rotator Cuff Injuries · United States.

Planned enrollment
62nd of 130
60 · median 60
Started
2025
with 10 others
No phase
86 of 168
21 open now
Primary completion
2026-10
later than 11 of 49 live
Registered
158th of 168
by date

Among the 168 studies in Rotator Cuff Injuries with a site in United States, this one is the 62nd largest by planned enrollment of the 130 interventional ones that give a count, is one of 11 that started in 2025, is one of 86 with no phase, reaches primary completion later than 11 of the 49 other live ones, and was the 158th registered.

Rotator Cuff Injuries

632 studies on the registry are indexed under Rotator Cuff Injuries; 157 are open to participants now.

Browse Rotator Cuff Injuries studies →

Open to participants now

40 of the 168 studies in Rotator Cuff Injuries with a site in United States are open now. Recruiting first, the newest first:

34 more — sign in →

All 40 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 100 Rotator Cuff Injuries studies recruiting now, 40 (40%) set no upper age limit and 41 (41%) stop at 75 or younger; 9 take children under 18; 10 take healthy volunteers.

This study: 30 Years to 70 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 168 studies in Rotator Cuff Injuries with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to prospectively evaluate healing, functional clinical outcomes, and safety of arthroscopic rotator cuff repairs augmented with the FiberLocker® System (encompassing the SpeedPatch® PET and the FiberLocker® Instrument).

The primary outcome measure is healing evaluation based on Magnetic Resonance Imaging (MRI) at a minimum of 6 months post-operatively.

The secondary outcome measures are the Sugaya classification, Goutallier Stage and tendon quality based on MRI as well as objective scores and patient-reported outcome measures (PROMs) from validated outcome scoring systems.

03

Conditions studied

  • Rotator Cuff Tear
  • Rotator Cuff Tears
  • Rotator Cuff Tears of the Shoulder

Browse trials for

Keywords

  • Rotator Cuff Tears
  • Rotator Cuff Repair
  • Augmentation
  • Reinforcement
  • Mechanical Augmentation
  • Rotator Cuff Degeneration
04

Who can participate

Ages eligible
30 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. The Subject is between the ages of 30 and 70 years.
  2. Subject is planning to undergo arthroscopic surgery for full-thickness rotator cuff tear (RCT)
  3. Tear size ≥ 2 cm
  4. Primary rotator cuff repair
  5. Subject preoperative MRI obtained within 1 year prior to surgery

Exclusion criteria

Exclusion Criteria:

  1. The Subject is unable or unwilling to sign the Patient , approved by the Institutional Review Board.
  2. The Subject objects to the use of the FiberLocker® System
  3. History or known allergy or intolerance to polyester
  4. Complete full-thickness subscapularis tears of > than the superior 1/3 of the tendon (Lafosse grade 3 and above)
  5. Hamada grade III and above
  6. Less than 2 mm joint space of the glenohumeral joint on either an anteroposterior or axillary radiograph
  7. Recurrent shoulder instability
  8. injection in the operative shoulder within three months before surgery
  9. Subjects with inflammatory or auto-immune based joint diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus)
  10. Subjects with current acute infection in the area surrounding the surgical site
  11. Revision rotator cuff repair
  12. Pregnant or planning to become pregnant during the study period
  13. Subject is breastfeeding during the study period
  14. Subject has conditions or circumstances that would interfere with study requirements
  15. The subject's condition represents a worker's compensation case

Intraoperative Exclusion Criteria:

  1. Partial rotator cuff repairs
  2. Lafosse grade 3 or higher subscapularis tears
  3. Limited space for implant delivery
  4. FiberLocker® System cannot be used as indicated
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Augmentation of Rotator Cuff Repair using the FiberLocker® System

    All enrolled participants will undergo repair of the rotator cuff tear, with augmentation utilizing the FiberLocker® System.

    Device: FiberLocker® System (encompassing FiberLocker® Instrument & SpeedPatch® PET)

Interventions

  • DeviceFiberLocker® System (encompassing FiberLocker® Instrument & SpeedPatch® PET)

    The FiberLocker® System is a mechanical augmentation system that includes an implant (SpeedPatch® PET) and an instrument (FiberLocker® Instrument) for its attachment. The implant is composed of non-woven PET fibers, and the instrument features a reciprocating needle at its tip, which pushes the individual patch fibers into the underlying tendon tissue.

06

What researchers measure

Primary outcomes

  1. Healing Evaluation

    The primary outcome measure is healing evaluation based on Magnetic Resonance Imaging (MRI) at a minimum of 6 months post-operatively. A standard shoulder MRI protocol utilizing a minimum of a 1.5 Tesla magnet will be utilized. The cuff integrity will be classified using the 5 categories described by Sugaya et al. Thereby, type IV and V are considered as retear and type I, II, and III as healed. The healing rate will be estimated and reported descriptively, and a 95% confidence interval will be reported assuming a binomial distribution (unless otherwise noted).

    Time frame: Pre-operatively & minimum 6 months post-operatively

Secondary outcomes

  1. Sugaya Classification

    The Sugaya Classification based on MRI images is used to evaluate the integrity of a repaired rotator cuff and to assess healing outcomes after a repair. The classification uses a categorial scoring system with grades from Type I to Type V. - Type I: Normal thickness and low signal intensity in all sections * Type II: Normal thickness and high signal intensity * Type III: Insufficient thickness without discontinuity, representing a partial-thickness tear * Type IV: Minor discontinuity (1-2 slices) on both oblique coronal and oblique sagittal images * Type V: Major discontinuity (\>2 slices) on both oblique coronal and sagittal images

    Time frame: Minimum 6 months post-operatively

  2. Goutallier Stage

    The Goutallier Classification is evaluated using MRI images to assess fatty infiltration and muscle degeneration in the rotator cuff. It has a categorial grading system from stage 0 to 4. Based on MRI images, the investigator classifies the rotator cuff of each subject. Thereby, a higher classification means more fatty infiltration.

    Time frame: Pre-operatively & minimum 6 months post-operatively

  3. Tendon Quality

    The tendon quality of each subject is graded based on MRI images using a categorial scoring system. The following classification can be used: Normal, Intact with edema/regularity, Partial tearing and/or abnormal tissue, Complete Tear/Abnormal.

    Time frame: Pre-operatively & minimum 6 months post-operatively

  4. American Shoulder and Elbow Surgeons (ASES) Score

    The ASES score is a patient-reported outcome measure survey which is completed by all subjects. It is used to assess shoulder function and pain. Based on the answers, a final score between 0 and 100 can be achieved. Thereby, higher scores indicate better shoulder function and less pain.

    Time frame: Pre-operatively, Post-operatively: 6 months, 12 months, 24 months

  5. Single Assessment Numeric Evaluation (SANE) Score

    The SANE score is a patient-reported outcome measure used to assess a patient's perception of their shoulder function. It consists of a single question and each subject has to rate their shoulder function on a scale from 0% to 100%. Thereby, higher percentages indicates better shoulder function.

    Time frame: Pre-operatively, Post-operatively: 6 months, 12 months, 24 months

  6. Visual Analog Scale for pain (VAS Score)

    The VAS Score is a patient-reported outcome measure used to assess pain intensity. All patients rate their pain on a horizontal line ranging from 0 to 10. Thereby, a higher score indicates greater pain intensity.

    Time frame: Pre-operatively, Post-operatively: 2 weeks, 6 months, 12 months, 24 months

  7. Veterans RAND 12-Item Health Survey (VR-12)

    The VR-12 is a patient-reported outcome measure assessing physical and mental health of the subjects. Based on their answers, the subjects can reach a score between 0 and 100, with a higher score indicating better health.

    Time frame: Pre-operatively, Post-operatively: 6 months, 12 months, 24 months

  8. Range of Motion (ROM) Assessment

    The subject's active ROM (based on the objective ASES score) is assessed using a goniometer. During an outpatient visit at the investigators facility, forward flexion, external rotation, abducted external rotation, abducted internal rotation and internal rotation will be evaluated. The unit of measure is degrees. If subjects are unable to return for an in person visit, an optional self-assessment of these range of motion form will be provided for electronic completion.

    Time frame: Pre-operatively, Post-operatively: 6 months, 12 months, 24 months

  9. Strength Assessment

    The strength of each subject will be evaluated (based on objective ASES) using a manual muscle testing device or other dynamometers. Thereby, external rotation strength, subscapularis strength-belly press and the constant score strength will be evaulated. The unit of measure will be kilograms or pounds.

    Time frame: Pre-operatively, Post-operatively: 6 months, 12 months, 24 months

  10. Constant-Murley Score

    The Constant-Murley Score will be assessed optionally. The score requires an outpatient visit at the investigator's facility and covers questions and functional assessments to assess pain, activity levels, range of motion and strength. The range of motion is assessed using a goniometer in degrees and the strength using a manual muscle testing device (or other dynamometers) in kilogram. The subjects can reach points between 0 and 100, whereby a higher score indicates better function.

    Time frame: Pre-operatively, Post-operatively: 6 months, 12 months, 24 months (all optional)

  11. (Serious) Adverse Events, (Serious) Adverse Device Effects and Device Deficiencies

    (Serious) Adverse Events, (Serious) Adverse Device Effects and Device Deficiencies will be reported by the research staff as soon as they occur.

    Time frame: From the surgical intervention to 24 months postoperatively

07

Study locations

4 of 4 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2025 (actual). Primary completion is estimated for Oct 2026, 13 months after the start.

Of 252 interventional studies with no phase under Rotator Cuff Injuries, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 13 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 6, 2025
First posted
Apr 9, 2025
StartActual
Aug 5, 2025
Primary completionEst.
Oct 1, 2026
CompletionEst.
Apr 1, 2028
Last update
Jul 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06918041
Lead sponsor
ZuriMED Technologies Inc.
Responsible party
Sponsor
First posted
Apr 9, 2025
Start date
Aug 5, 2025
Primary completion
Oct 1, 2026 (estimated)
Completion
Apr 1, 2028 (estimated)
Last update
Jul 8, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion